Rising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
more
Stories about Krankheit
Leipzig Tourismus und Marketing GmbH
5Pioneering Heart Surgery and Medical Congresses in Leipzig
One documentmoreTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical Trial
moreWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
moreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmoreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
more
Cells of the Future: A Key To Reprogramming Cell Identities
moreNew Source of Stem Cells in Injury-Affected Brains of Patients
moreLTS Lohmann Therapie-Systeme AG
LTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patches
moreTen benefits of a daily intake of citrus fruits during winter season
more- 2
PIONEER+ becomes Big Data Platform for Prostate Cancer of the EAU's UroEvidenceHub
more The easiest fruit celebrates its 'Apple Day'
more
- 3
EU Provides 1 Mio. to Researchers to Advance Personalised Oncology
One documentmore canSERV Releases Open Call for Transnational Service Provision
One documentmoreDeepMB: A Deep Learning Framework For High-Quality Optoacoustic Imaging in Real-Time
more- 2
Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey reveals
One documentmore - 2
Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and Specialty
One documentmore A New Ally in Fighting Brain Diseases: Our Very Own Skull
more
- 4
PIONEER Big Data in Prostate Cancer Platform Opens up to Asian Data Sets
more Life Science Factory to Open a New Location in Munich in 2024
moreWildDISCO: Visualizing Whole Bodies in Unprecedented Detail
morePotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
more
RHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreBerlin Cures Welcomes Oliver von Stein as New CEO to Lead Next Phase of Innovation and Growth / Phase II study for BC 007 in the indication Long COVID to start in June
more- 3
Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca Biotech
more - 5
Press Release - hubergroup India expands its support for rural healthcare
One documentmore The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
more- 2
Free Access to Cancer Research Services - canSERV 1st Call for Proposals
more
Previous12345Next